All Stories

  1. Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway

    Article • Oxidative Medicine and Cellular Longevity, December 2019, Hindawi Publishing Corporation

    Qizhu Tang

  2. The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPARα

    Article • Oxidative Medicine and Cellular Longevity, November 2019, Hindawi Publishing Corporation

    Qizhu Tang, Xie Saiyang

  3. Protection against Doxorubicin-Induced Cytotoxicity by Geniposide Involves AMPKα Signaling Pathway

    Article • Oxidative Medicine and Cellular Longevity, June 2019, Hindawi Publishing Corporation

    Qizhu Tang

  4. Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy

    Article • Disease Markers, December 2018, Hindawi Publishing Corporation

    Qizhu Tang, Rongxin Geng

  5. Long title: C1q-tumor necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice

    Article • Cardiovascular Research, November 2018, Oxford University Press (OUP)

    Qizhu Tang

  6. Geniposide Protects against Obesity-Related Cardiac Injury through AMPKα- and Sirt1-Dependent Mechanisms

    Article • Oxidative Medicine and Cellular Longevity, November 2018, Hindawi Publishing Corporation

    Qizhu Tang

  7. Aucubin Protects against Myocardial Infarction-Induced Cardiac Remodeling via nNOS/NO-Regulated Oxidative Stress

    Article • Oxidative Medicine and Cellular Longevity, June 2018, Hindawi Publishing Corporation

    Qizhu Tang

  8. Pioglitazone Alleviates Cardiac Fibrosis and Inhibits Endothelial to Mesenchymal Transition Induced by Pressure Overload

    Article • Cellular Physiology and Biochemistry, December 2017, Karger Publishers

    Qizhu Tang

  9. Myricetin attenuated LPS induced cardiac injury in vivo and in vitro

    Article • Phytotherapy Research, December 2017, Wiley

    Qizhu Tang

  10. Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy

    Article • Journal of Cellular Biochemistry, May 2017, Wiley

    Qizhu Tang

  11. The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure

    Article • Current Pharmaceutical Design, May 2017, Bentham Science Publishers

    Qizhu Tang

  12. Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress

    Article • Cellular Physiology and Biochemistry, January 2017, Karger Publishers

    Qizhu Tang

  13. Serum Biomarker Identification by Mass Spectrometry in Acute Aortic Dissection

    Article • Cellular Physiology and Biochemistry, January 2017, Karger Publishers

    Qizhu Tang

  14. Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1

    Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

    Qizhu Tang

  15. Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition

    Article • PPAR Research, January 2017, Hindawi Publishing Corporation

    Qizhu Tang

  16. Red Blood Cell Distribution Width: A Novel Predictive Indicator for Cardiovascular and Cerebrovascular Diseases

    Article • Disease Markers, January 2017, Hindawi Publishing Corporation

    Qizhu Tang

  17. Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway

    Article • British Journal of Pharmacology, March 2016, Wiley

    Qizhu Tang

  18. Nobiletin Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Proliferation and Migration and Attenuates Neointimal Hyperplasia in a Rat Carotid Artery Injury Model

    Article • Drug Development Research, November 2014, Wiley

    Qizhu Tang